Rallybio Corporation (RLYB)
NASDAQ: RLYB · Real-Time Price · USD
4.750
+0.099 (2.13%)
Feb 6, 2026, 4:00 PM EST - Market closed
Rallybio Market Cap
Rallybio has a market cap or net worth of $25.08 million as of February 6, 2026. Its market cap has decreased by -33.96% in one year.
Market Cap
25.08M
Enterprise Value
-34.04M
1-Year Change
-33.96%
Ranking
Category
Stock Price
$4.75
Market Cap Chart
Since the IPO on July 29, 2021, Rallybio's market cap has decreased from $405.60M to $25.08M, a decrease of -93.82%. That is a compound annual growth rate of -45.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 25.08M | -13.46% |
| Dec 31, 2025 | 28.98M | -27.23% |
| Dec 31, 2024 | 39.83M | -55.91% |
| Dec 29, 2023 | 90.33M | -63.67% |
| Dec 30, 2022 | 248.60M | -18.90% |
| Dec 31, 2021 | 306.52M | -24.43% |
| Jul 29, 2021 | 405.60M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Serina Therapeutics | 26.64M |
| Lixte Biotechnology Holdings | 26.31M |
| BriaCell Therapeutics | 26.02M |
| AEON Biopharma | 25.71M |
| Skye Bioscience | 25.63M |
| Boundless Bio | 24.40M |
| Evaxion | 24.27M |
| Palatin Technologies | 24.26M |